4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-022473
Chief Financial Officer sold 5,417 shares at $2.22 ($12,026)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mostafa Adam S. Chief Financial Officer | 2023-06-15 | Sale | −5,417 | $2.22 | $12,026 | 88,279 | D |
| Open-market sales · 5,417 sh · avg $2.22 · $12,026 | |||||||
Loading xslF345X04/wk-form4_1686946623.xml…